Medx Health Corp.

As of June 30, 2026, Medx Health Corp. carries a market capitalization of 18.04M, placing it among publicly traded companies globally. Its enterprise value stands at 26.71M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medx Health Corp.'s next confirmed earnings release is scheduled for December 2, 2026.

As of June 30, 2026, Medx Health Corp. has 327.93M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 31.02, and the price-to-book ratio stands at -1.69.

These figures are as of June 30, 2026. The EV/Sales ratio of 46.87 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 26.71M versus a market cap of 18.04M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Medx Health Corp. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -81.23, indicating conservative leverage, while an interest coverage ratio of -2.52 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -837.92, reflecting losses generated across the asset base. Inventory turnover of 1.40 indicates how many times Medx Health Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on August 25, 2026, Medx Health Corp.'s stock has declined approximately 30.77% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.06.

Over the twelve months ended June 30, 2026, Medx Health Corp. generated 569,792.00 in revenue and converted that into -6.19M in net income, yielding earnings per share of -0.02. EBITDA reached -4.22M, while operating income came in at -4.28M.

As of June 30, 2026, Medx Health Corp. holds 19,592.00 in cash and equivalents against 8.69M in total debt, resulting in a net debt position of 8.41M. Total book value stands at -10.70M, with working capital of -9.28M providing operational flexibility.

Medx Health Corp. produced -3.77M in operating cash flow over the twelve months ended June 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -3.77M - equivalent to -0.01 per share.

Over the twelve months ended June 30, 2026, Medx Health Corp. posted a gross margin of 33.09, reflecting its pricing power and cost economics. The operating margin of -750.44 and net profit margin of -1,085.95 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -21.33: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -20.31, meaning Medx Health Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Medx Health Corp. has an Altman Z-Score of -233.25, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.